Evidence map›Paper›PMID 39237863›Full record

ArticleBMC neurology2024

Primary neurolymphomatosis with MAG antibody: a case report.

Honglian Zhang, Si Chen, Jing Li, Huan Yang, Yue-Bei Luo

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Honglian ZhangDepartment of neurology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Department of Neurology, Xiangya Hospital, Central South University, Jiangxi, National Regional Center for Neurological Diseases, Nanchang, 330000, Jiangxi, China.
Si ChenDepartment of Neurology, Xiangya Hospital Central South University, Changsha, 410000, Hunan, China.
Jing LiDepartment of Neurology, Xiangya Hospital Central South University, Changsha, 410000, Hunan, China.
Huan YangDepartment of Neurology, Xiangya Hospital Central South University, Changsha, 410000, Hunan, China.
Yue-Bei LuoDepartment of Neurology, Xiangya Hospital Central South University, Changsha, 410000, Hunan, China. yuebei507@csu.edu.cn.

Funding

the Jiangxi Provincial Health Commission science and technology plan No.202310152the Science and Technology Plan of Jiangxi Provincial Administration of Traditional Chinese Medicine No.2022B563
6 · The paper itself

Abstract

Neurolymphomatosis (NL) is a rare neurologic manifestation of non-Hodgkin lymphoma (NHL) with poor prognosis. Investigations including MRI, PET/CT, nerve biopsy and cerebrospinal fluid (CSF) analysis can aid the diagnosis of NL. In this study, we presented a case of NL with co-existing myelin-associated glycoprotein (MAG) antibody. The patient first presented with symptoms of peripheral neuropathy involving multiple cranial nerves and cauda equina, and later developed obstructive hydrocephalus and deep matter lesions. He also had persistently positive MAG antibody, but did not develop electrophysiologically proven neuropathy and monoclonal immunoglobulin. The final brain biopsy confirmed diffuse large B cell lymphoma.

Indexed as

Myelin-Associated GlycoproteinNeurolymphomatosisAgedAutoantibodiesHumansLymphoma, Large B-Cell, DiffuseMaleAutoantibodiesMyelin-Associated GlycoproteinCranial neuropathyMAG antibodyNeurolymphomatosisRituximab

Identifiers

PMID39237863
PMCPMC11375887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.